{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:53:35Z","timestamp":1793444015053,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Prostatic cancer is uncommon in dogs. Dogs with prostatic carcinoma have been reported to have a poor prognosis. Information regarding prognosis with various surgery options as well as prognosis with surgical vs. medical treatment is lacking. This retrospective study compares the outcomes of medical management to surgical treatment in dogs with prostatic adenocarcinoma and assesses the surgical outcomes of patients who underwent total prostatectomy (TP) and prostatocystectomy (TPC). The medical records of 41 dogs with prostatic adenocarcinoma, between February 2008 and June 2019, were reviewed for information on signalment, clinical signs in the initial evaluation, preoperative diagnostic imaging findings, treatment type (non-surgical or surgical), surgery type, postoperative complications, adjunctive medical therapy, and survival time. The dogs were divided into non-surgical (<jats:italic>n<\/jats:italic>\u2009=\u200912) or surgical (<jats:italic>n<\/jats:italic>\u2009=\u200929) groups. The surgical group was subdivided into the TP (<jats:italic>n<\/jats:italic>\u2009=\u200920) and TPC (<jats:italic>n<\/jats:italic>\u2009=\u20099) subgroups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Age was not significantly different between the surgical (median 13.1\u2009years [8.4\u201315.4] years) and the non-surgical groups (median 10.8 [7.7\u201315.3] years). Body weight (BW) was also not significantly different between the surgical (median 6.8\u2009kg [2.4\u201334.5\u2009kg]) and non-surgical groups (median 6.4\u2009kg [3.7\u20139.12\u2009kg]). The overall median survival time (MST) from the initial evaluation was significantly longer in the surgical than in the non-surgical group (337 vs. 90.5\u2009days). The postoperative MST was significantly longer in the TP group than in the TPC subgroup (510 vs. 83\u2009days). As TPC was performed in cases of tumor progression, its postoperative complications were severe, resulting in a shorter MST. Ten (50%) and 6 patients (30%) in the TP subgroup postoperatively showed mild and severe urinary incontinence, respectively, whereas all patients in TPC subgroup did show severe incontinence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Results of the study suggest that surgical treatment of prostatic carcinoma results in longer survival times over medical management alone. In particular, TP might be recommended for improving survival time and quality of life in canine prostatic adenocarcinoma that does not infiltrate the bladder. Early detection is key for a survival advantage with surgical treatment.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-021-03103-5","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T07:03:09Z","timestamp":1642230189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of outcomes between medical and surgical treatment in dogs with prostatic adenocarcinoma: a retrospective study"],"prefix":"10.1186","volume":"18","author":[{"given":"Keigo","family":"Iizuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamiko","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nagumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Terai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"key":"3103_CR1","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2460\/javma.1992.200.08.1119","volume":"200","author":"DR Krawiec","year":"1992","unstructured":"Krawiec DR, Helfin D. Study of prostatic disease in dogs: 177 cases (1981\u20131986). J Am Vet Med Assoc. 1992;200:1119\u201322.","journal-title":"J Am Vet Med Assoc"},{"key":"3103_CR2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/pros.20590","volume":"67","author":"JN Bryan","year":"2007","unstructured":"Bryan JN, Keeler MR, Henry CJ, Bryan ME, Hahn AW, Caldwell CW. A population study of neutering status as a risk factor for canine prostate cancer. Prostate. 2007;67:1174\u201381.","journal-title":"Prostate."},{"issue":"Suppl 2","key":"3103_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/rda.12296","volume":"49","author":"X L\u00e9vy","year":"2014","unstructured":"L\u00e9vy X, Ni\u017ca\u0144ski W, von Heimendahl A, Mimouni P. Diagnosis of common prostatic conditions in dogs: an update. Reprod Domest Anim. 2014;49(Suppl 2):50\u20137.","journal-title":"Reprod Domest Anim"},{"key":"3103_CR4","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2460\/javma.1991.199.11.1623","volume":"199","author":"FW Bell","year":"1991","unstructured":"Bell FW, Klausner JS, Hayden DW, Feeney DA, Johnston SD. Clinical and pathologic features of prostatic adenocarcinoma in sexually intact and castrated dogs: 31 cases (1970-1987). J Am Vet Med Assoc. 1991;199:1623\u201330.","journal-title":"J Am Vet Med Assoc"},{"key":"3103_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/1097-0045(20001001)45:2<173::AID-PROS12>3.0.CO;2-R","volume":"45","author":"KK Cornell","year":"2000","unstructured":"Cornell KK, Bostwick DG, Cooley DM, Hall G, Harvey HJ, Hendrick MJ. Clinical and pathological aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases. Prostate. 2000;45:173\u201383.","journal-title":"Prostate"},{"key":"3103_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.tvjl.2008.07.012","volume":"180","author":"BE Leroy","year":"2009","unstructured":"Leroy BE, Northrup N. Prostate cancer in dogs: comparative and clinical aspects. Vet J. 2009;180:149\u201362.","journal-title":"Vet J"},{"key":"3103_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1476-5810.2004.00035.x","volume":"2","author":"KU Sorenmo","year":"2004","unstructured":"Sorenmo KU, Goldschmidt MH, Shofer FS, Goldkamp C, Ferracone J. Evaluation of cyclooxygenase-1 and cyclooxygenase-2 expression and the effect of cyclooxygenase inhibitors in canine prostatic carcinoma. Vet Comp Oncol. 2004;2:13\u201323.","journal-title":"Vet Comp Oncol"},{"key":"3103_CR8","first-page":"16","volume":"11","author":"TN Hazzar","year":"2013","unstructured":"Hazzar TN, Kass PH, Brodsky EM, Elpiner AK, Silver ML, Buote NJ. Evaluation of mitoxantrone with piroxicam as first line therapy for carcinomas of the prostate in dogs. Intern J Appl Res Vet Med. 2013;11:16\u201324.","journal-title":"Intern J Appl Res Vet Med"},{"key":"3103_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/vco.12400","volume":"16","author":"S Ravicini","year":"2018","unstructured":"Ravicini S, Baines SJ, Taylor A, Amores-Fuster I, Mason SL, Treggiari E. Outcome and prognostic factors in medically treated canine prostatic carcinomas: a multi-institutional study. Vet Comp Oncol. 2018;16:450\u20138.","journal-title":"Vet Comp Oncol"},{"key":"3103_CR10","unstructured":"Vail DM, Thamm D, Liptak JM. Withrow and MacEwen's Small Animal Clinical Oncology E-book (p.634). Elsevier Health Sciences; 2019. p. 634."},{"key":"3103_CR11","first-page":"50","volume":"20","author":"EM Hardie","year":"1984","unstructured":"Hardie EM, Barsanti JA, Rawlings CA. Complications of prostatic surgery. J Am Anim Hosp Assoc. 1984;20:50\u20136.","journal-title":"J Am Anim Hosp Assoc"},{"key":"3103_CR12","first-page":"385","volume":"25","author":"RR Basinger","year":"1989","unstructured":"Basinger RR, Rawlings CA, Barsanti JA, Oliver JE. Urodynamic alterations associated with clinical prostate disease and prostatic surgery in 23 dogs. J Am Anim Hosp Assoc. 1989;25:385\u201392.","journal-title":"J Am Anim Hosp Assoc"},{"key":"3103_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1532-950X.1991.tb01255.x","volume":"20","author":"SE Goldsmid","year":"1991","unstructured":"Goldsmid SE, Bellenger CR. Urinary incontinence after prostatectomy in dogs. Vet Surg. 1991;20:253\u20136.","journal-title":"Vet Surg"},{"key":"3103_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1748-5827.2006.00063.x","volume":"47","author":"M Vlasin","year":"2006","unstructured":"Vlasin M, Rauser P, Fichtel T, Necas A. Subtotal intracapsular prostatectomy as a useful treatment for advanced\u2013stage prostatic malignancies. J Small Anim Pract. 2006;47:512\u20136.","journal-title":"J Small Anim Pract"},{"key":"3103_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/vsu.12768","volume":"47","author":"TC Bennett","year":"2018","unstructured":"Bennett TC, Matz BM, Henderson RA, Straw RC, Liptak JM, Selmic LE. Total prostatectomy as a treatment for prostatic carcinoma in 25 dogs. Vet Surg. 2018;47:367\u201377.","journal-title":"Vet Surg"},{"key":"3103_CR16","first-page":"141","volume":"57","author":"N Bacon","year":"2016","unstructured":"Bacon N, Souza CH, Franz S. Total cysto-prostatectomy: technique description and results in 2 dogs. Can Vet J. 2016;57:141\u20136.","journal-title":"Can Vet J."},{"key":"3103_CR17","doi-asserted-by":"crossref","unstructured":"Foster JA, Palit V, Myatt A, Hadi S, Bryan NP. Technical description and outcomes of a continuous anastomosis in open radical prostatectomy. BJU Int. 2009:929\u201333.","DOI":"10.1111\/j.1464-410X.2009.08526.x"},{"key":"3103_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1532-950X.1988.tb00293.x","volume":"17","author":"EA Stone","year":"1988","unstructured":"Stone EA, Withrow SJ, Page RL, Schwarz PD, Wheeler SL, Seim HB 3rd. Ureterocolonic anastomosis in ten dogs with transitional cell carcinoma. Vet Surg. 1988;17:147\u201353.","journal-title":"Vet Surg"},{"key":"3103_CR19","first-page":"73","volume":"56","author":"K Saeki","year":"2015","unstructured":"Saeki K, Fujita A, Fujita N, Nakagawa T, Nishimura R. Total cystectomy and subsequent urinary diversion to the prepuce or vagina in dogs with transitional cell carcinoma of the trigone area: a report of 10 cases (2005\u20132011). Can Vet J. 2015;56:73\u201380.","journal-title":"Can Vet J"},{"key":"3103_CR20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1740-8261.2011.01907.x","volume":"53","author":"C McDonald","year":"2012","unstructured":"McDonald C, Looper J, Greene S. Response rate and duration associated with a 4Gy 5 fraction palliative radiation protocol. Vet Radiol Ultrasound. 2012;53:358\u201364.","journal-title":"Vet Radiol Ultrasound"},{"key":"3103_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1532-950x.2004.04067.x","volume":"33","author":"JM Liptak","year":"2004","unstructured":"Liptak JM, Brutscher SP, Monnet E, Dernell WS, Twedt DC, Kazmierski KJ. Transurethral resection in the management of urethral and prostatic neoplasia in 6 dogs. Vet Surg. 2004;33:505\u201316.","journal-title":"Vet Surg"},{"key":"3103_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1532-950X.2006.00165.x","volume":"35","author":"HF L\u2019Eplattenier","year":"2006","unstructured":"L\u2019Eplattenier HF, van Nimwegen SA, van Sluijs FJ, Kirpensteijn J. Partial prostatectomy using Nd:YAG laser for management of canine prostate carcinoma. Vet Surg. 2006;35:406\u201311.","journal-title":"Vet Surg"},{"key":"3103_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2460\/javma.229.2.226","volume":"229","author":"C Weisse","year":"2006","unstructured":"Weisse C, Berent A, Todd K, Clifford C, Solomon J. Evaluation of palliative stenting for management of malignant urethral obstructions in dogs. J Am Vet Med Assoc. 2006;229:226\u201334.","journal-title":"J Am Vet Med Assoc"},{"key":"3103_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tvjl.2007.08.001","volume":"178","author":"HF L\u2019Eplattenier","year":"2008","unstructured":"L\u2019Eplattenier HF, Klem B, Teske E, van Sluijs FJ, van Nimwegen SA, Kirpensteijn J. Preliminary results of intraoperative photodynamic therapy with 5-aminolevulinic acid in dogs with prostate carcinoma. Vet J. 2008;178:202\u20137.","journal-title":"Vet J"},{"key":"3103_CR25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.eururo.2004.12.006","volume":"47","author":"S Joniau","year":"2005","unstructured":"Joniau S, Benijts J, Van Kampen M, De Waele M, Ooms J, Van Cleynenbreugel B. Clinical experience with the N-shaped ileal neobladder: assessment of complications, voiding patterns, and quality of life in our series of 58 patients. Eur Urol. 2005;47:666\u201372.","journal-title":"Eur Urol"},{"key":"3103_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/jjco\/hyu051","volume":"44","author":"SH Kim","year":"2014","unstructured":"Kim SH, Yu A, Jung JH, Lee YJ, Lee ES. Incidence and risk factors of 30-days early and 90-day late morbidity and mortality of radical cystectomy during a 13-year follow-up: a comparative propensity-score matched analysis of complications between neobladder and ileal conduit. Jpn J Clin Oncol. 2014;44:677\u201385.","journal-title":"Jpn J Clin Oncol"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-021-03103-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-021-03103-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-021-03103-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T10:35:39Z","timestamp":1726482939000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-021-03103-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3103"],"URL":"https:\/\/doi.org\/10.1186\/s12917-021-03103-5","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"7 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All applicable international, national, and institutional guidelines for the care and use of animals were followed. This study was approved by the Ethical Committee of Nihon University Animal Medical Center (accession No. ANMEC-3-009).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest related to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}